| Name | Title | Contact Details |
|---|
The Mitsubishi UFJ Financial Group (MUFG) is one of the world’s leading financial groups, with total assets of approximately $2.3 trillion (USD)1 as of June 30, 2015. Our services include corporate banking, commercial banking, retail banking, wealth management, investment banking, capital markets, personal and corporate trust, and transaction banking. In 2014, MUFG integrated the U.S. operations of its subsidiary The Bank of Tokyo-Mitsubishi UFJ, Ltd. (BTMU) with those of San Francisco-based Union Bank, N.A. This combined entity — MUFG Union Bank, N.A., allows us to better serve our individual, corporate, and institutional customers in the United States, Canada, and Latin America by offering expanded global capabilities. In the Americas, we service our corporate and investment banking customers under the MUFG brand, and we go to market with our retail, wealth, and commercial banking customers under the Union Bank® brand. BTMU is Japan’s premier bank, with a global network spanning more than 40 countries. It is one of the largest foreign banks operating in North America, the company’s primary overseas market, and has been in Latin America for more than 90 years. Founded in 1864, Union Bank is one of the oldest financial institutions in the American West and was instrumental to the growth of California. Its retail operations include more than 400 branches in California, Oregon, and Washington.
Gluskin Sheff Associates, Inc. is a Toronto, ON-based company in the Financial Services sector.
Zephyr Management LP is a New York, NY-based company in the Financial Services sector.
BullFrog AI is an investor-backed company determined to become the undisputed leader in precision medicine. Our mission is to find the link between therapies and patients, and improve their lives. Using our proprietary technology platform, we aim to predict which patients will benefit from which medications, effectively improving clinical outcomes and eliminating the problem of trial-and-error prescriptions. We have an exceptional team of life science industry leaders, AI technologists, scientists, physicians and advisors determined to help BullFrog AI revolutionize drug development. Through our partnership with one of the most prestigious research institutions in the world, we take pride in technology innovation by staying on the cutting edge of AI.
Section 32 focus areas include biotechnology, therapeutics, advanced diagnostics, precision medicine, software, cybersecurity, machine learning, and artificial intelligence.